HD LifeSciences expanded its patent portfolio with the issuance of U.S. Patent No. 10,888,429 B2, Three-Dimensional Lattice Structures for Implants. The patent relates to an anisotropic load-bearing low stiffness lattice structure, as well as the capability to tailor these properties to a specific purpose such as 3D-printed titanium interbody cages.
HD’s lattice structure allows the sufficient strength of the interbody to provide stability during daily life, while allowing load-sharing with newly forming bone.
“This technology allows implants to further match physiological conditions as they vary with loading direction. Combined with the lattice’s internal volume curated to match the physiological dimensionality of bone substrates, this provides a strong tool for bone formation,” said Ian Helmar, Vice President of Research & Development at HD LifeSciences.
HD LifeSciences expanded its patent portfolio with the issuance of U.S. Patent No. 10,888,429 B2, Three-Dimensional Lattice Structures for Implants. The patent relates to an anisotropic load-bearing low stiffness lattice structure, as well as the capability to tailor these properties to a specific purpose such as 3D-printed titanium interbody...
HD LifeSciences expanded its patent portfolio with the issuance of U.S. Patent No. 10,888,429 B2, Three-Dimensional Lattice Structures for Implants. The patent relates to an anisotropic load-bearing low stiffness lattice structure, as well as the capability to tailor these properties to a specific purpose such as 3D-printed titanium interbody cages.
HD’s lattice structure allows the sufficient strength of the interbody to provide stability during daily life, while allowing load-sharing with newly forming bone.
“This technology allows implants to further match physiological conditions as they vary with loading direction. Combined with the lattice’s internal volume curated to match the physiological dimensionality of bone substrates, this provides a strong tool for bone formation,” said Ian Helmar, Vice President of Research & Development at HD LifeSciences.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
